CCL5 and breast carcinoma: The CAAs modulate, for instance, the behavior of breast cancer cells via the release of pro-inflammatory mediators such as IL-6, TNF-α, CCL2, or CCL5, promoting angiogenesis, proliferation, and metastasis [126,127,128].